Guidelines on the use of acitretin in Pakistan
DOI:
https://doi.org/10.66344/jpad.24.3.2014.236Keywords:
Acitretn, guidelines, psoriasisAbstract
Actretin is a second generation retinoid which is commonly used in psoriasis and many other disorders of keratinization. The present review focuses on its uses, side effects and monitoring in the local perspective.References
Kragballe K, Jansen CT, Geiger JM et al. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study. Acta Derm Venereol. 1989;69:35-40.
Larsen FG, Jakobsen P, Knudsen J et al. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol. J Invest Dermatol. 1993;100:623-7.
Chandraratna RA. Rational design of receptor-selective retinoids. J Am Acad Dermatol. 2010;39(4 Pt 2):S124–8.
Hardin J, Mydlarski PR. Systemic retinoids: chemoprevention of skin cancer in transplant recipients. Skin Therapy Lett. 2010;15:1-4.
Ormerod AD, Campalani E, Goodfield MJ. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol. 2010;162:952-63.
Geiger JM. Efficacy of acitretin in severe psoriasis. Skin Therapy Lett. 2003;8(4):1-3.
Laurberg G, Geiger JM, Hjorth N et al. Treatment of lichen planus with acitretin. A double-blind, placebo-controlled study in 65 patients. J Am Acad Dermatol. 1991;24:434–7.
Thestrup-Pedersen K, Andersen KE, Menne T et al. Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo-controlled study. Acta Derm Venereol. 2001;81:353-5.
Chapalain V, Beylot-Barry M, Doutre MS et al. Treatment of pityriasis rubra pilaris: a retrospective study of 14 patients. J Dermatolog Treat. 1999;10:113-7.
van Dooren-Greebe RJ, van de Kerkhof PC, Happle R. Acitretin monotherapy in Darier's disease. Br J Dermatol. 1989;121:375-9.
Bousema MT, Romppanen U, Geiger JM et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol. 1994;30(2 Pt 1):225–31.
Lacour M, Mehta-Nikhar B, Atherton DJ et al. An appraisal of acitretin therapy in children with inherited disorders of keratinization. Br J Dermatol. 1996;134:1023-9.
Gupta AK, Goldfarb MT, Ellis CN et al. Side-effect profile of acitretin therapy in psoriasis. J Am Acad Dermatol. 1989;20:1088-93.
Kullavanijaya P, Kulthanan K. Clinical efficacy and side effects of acitretin on the disorders of keratinization: a one-year study. J Dermatol. 1993;20:501-6.
Ling MR. Acitretin: optimal dosing strategies. J Am Acad Dermatol. 1999;41(3 Pt 2):S13-7.
Geiger JM, Czarnetzki BM. Acitretin (Ro 10–1670, etretin): overall evaluation of clinical studies. Dermatologica. 1988;176:182-90.
Oxford Centre for Evidence-based Medicine Levels of Evidence (March 2009). http://www.cebm.net/?o=1116).
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
